Notice2022-03616
Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 22, 2022
Issuing agencies
Health and Human Services DepartmentSubstance Abuse and Mental Health Services Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 35 (Tuesday, February 22, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
[Notices]
[Pages 9631-9632]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-03616]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory
Board (DTAB) will convene via web conference on March 9, 2022, from
10:00 a.m. ET to 1:00 p.m. ET.
The board will meet in open-session on March 9, 2022, from 10:00
a.m. ET to 1:00 p.m. ET, to discuss the Mandatory Guidelines for
Federal Workplace Drug Testing Programs with updates from the
Department of Transportation, the Nuclear Regulatory Commission and the
Food and Drug
[[Page 9632]]
Administration. Other discussion topics include a presentation on the
Drug-Free Workplace Program Summit meeting scheduled for May, 2022,
NLCP drug testing results, and synthetic urines and adulteration.
Meeting registration information can be completed at <a href="http://snacregister.samhsa.gov/MeetingList.aspx">http://snacregister.samhsa.gov/MeetingList.aspx</a>. Web conference and call
information will be sent after completing registration. Meeting
information and a roster of DTAB members may be obtained by accessing
the SAMHSA Advisory Committees website, <a href="https://www.samhsa.gov/about-us/advisory-councils/meetings">https://www.samhsa.gov/about-us/advisory-councils/meetings</a> or by contacting the Designated Federal
Officer, Lisa S. Davis, M.S.
Committee Name: Substance Abuse and Mental Health Services
Administration, Center for Substance Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: March 9, 2022, from 10:00 a.m. to 1:00 p.m.: OPEN.
Place: Substance Abuse and Mental Health Services Administration,
5600 Fishers Lane, Rockville, MD 20857.
Contact: Lisa S. Davis, M.S., Social Science Analyst, Center for
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland
20857, Telephone: (240) 276-1440, Email: <a href="/cdn-cgi/l/email-protection#ca86a3b9abe48eabbca3b98ab9aba7a2b9abe4a2a2b9e4ada5bc"><span class="__cf_email__" data-cfemail="c884a1bba9e68ca9bea1bb88bba9a5a0bba9e6a0a0bbe6afa7be">[email protected]</span></a>.
Anastasia Marie Donovan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2022-03616 Filed 2-18-22; 8:45 am]
BILLING CODE 4162-20-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 22, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.